Year |
Citation |
Score |
2019 |
Johnston RJ, Su LJ, Pinckney J, Critton D, Boyer E, Krishnakumar A, Corbett M, Rankin AL, Dibella R, Campbell L, Martin GH, Lemar H, Cayton T, Huang RY, Deng X, ... ... Bahjat KS, et al. VISTA is an acidic pH-selective ligand for PSGL-1. Nature. 574: 565-570. PMID 31645726 DOI: 10.1038/S41586-019-1674-5 |
0.324 |
|
2019 |
Zebertavage L, Bambina S, Shugart J, Alice A, Zens KD, Lauer P, Hanson B, Gough MJ, Crittenden MR, Bahjat KS. A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity. Plos One. 14: e0209153. PMID 30601871 DOI: 10.1371/Journal.Pone.0209153 |
0.379 |
|
2017 |
Alice AF, Kramer G, Bambina S, Baird JR, Bahjat KS, Gough MJ, Crittenden MR. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 29150567 DOI: 10.4049/Jimmunol.1700909 |
0.45 |
|
2016 |
Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ. Designer vaccine nanodiscs for personalized cancer immunotherapy. Nature Materials. PMID 28024156 DOI: 10.1038/Nmat4822 |
0.336 |
|
2015 |
Koguchi Y, Hoen HM, Bambina SA, Rynning MD, Fuerstenberg RK, Curti BD, Urba WJ, Milburn C, Bahjat FR, Korman AJ, Bahjat KS. Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab. Cancer Research. 75: 5084-92. PMID 26627641 DOI: 10.1186/2051-1426-3-S2-P96 |
0.673 |
|
2015 |
Baird JR, Friedman D, Cottam B, Dubensky TW, Kanne DB, Bambina S, Bahjat K, Crittenden MR, Gough MJ. Radiation therapy combined with novel STING-targeting oligonucleotides results in regression of established tumors. Cancer Research. PMID 26567136 DOI: 10.1158/0008-5472.Can-14-3619 |
0.378 |
|
2015 |
Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Bahjat K, et al. Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 399-400. PMID 25732764 DOI: 10.1038/Cr.2015.28 |
0.396 |
|
2015 |
Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Bahjat K, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 208-24. PMID 25582080 DOI: 10.1038/Cr.2015.3 |
0.47 |
|
2015 |
Crittenden M, Bahjat KS, Li R, Gore PA, Fountain C, Hanson B, Skoble J, Lauer P, Murphy A, Dubensky TW, Brockstedt DG, Urba WJ. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated Listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRvIII and NY-ESO-1, in patients with WHO grade III/IV astrocytomas. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps3106 |
0.378 |
|
2015 |
Uhde L, Bambina S, Alice A, Lauer P, Crittenden M, Bahjat KS, Gough M. Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma Journal For Immunotherapy of Cancer. 3: 78. DOI: 10.1186/2051-1426-3-S2-P78 |
0.359 |
|
2015 |
Ramos R, Lee A, Chan A, Bahjat KS, Foshag L, Faries M, Lee D, Sieling P. γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases Journal For Immunotherapy of Cancer. 3: 312. DOI: 10.1186/2051-1426-3-S2-P312 |
0.401 |
|
2015 |
Koguchi Y, Meeuwsen T, Gonzalez I, Miller W, Bahjat KS. A scalable platform for clinical immunophenotyping: assay design and quality control for high complexity flow cytometry Journal For Immunotherapy of Cancer. 3: 251. DOI: 10.1186/2051-1426-3-S2-P251 |
0.319 |
|
2015 |
Crittenden M, Bahjat KS, Li R, Gore P, Fountain C, Hanson B, Skoble J, Lauer P, Murphy AL, Dubensky T, Brockstedt DG, Urba W. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas Journal For Immunotherapy of Cancer. 3: 162. DOI: 10.1186/2051-1426-3-S2-P162 |
0.349 |
|
2015 |
Curti BD, Akporiaye E, Sutcliffe K, Bahjat KS, Koguchi Y, Cramer J, Urba W. Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P148 |
0.31 |
|
2014 |
Puri S, Han J, Joshi BH, Healy D, Siebert J, Paustian C, Dubay C, Bahjat KS, Curti B, Urba WJ, Fox BA. Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer Journal For Immunotherapy of Cancer. 2: 257. DOI: 10.1186/2051-1426-2-S3-P257 |
0.337 |
|
2014 |
Sanborn R, Boulmay B, Li R, Spieler B, Happel K, Paustian C, Mougdil T, Feng Z, Dubay C, Fisher B, Koguchi Y, Aung S, Mederos E, Bifulco C, McNamara M, ... Bahjat KS, et al. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC Journal For Immunotherapy of Cancer. 3: 435. DOI: 10.1186/2051-1426-2-S3-P249 |
0.326 |
|
2014 |
Baird JR, Dubensky TW, Kanne DB, Friedman DJ, Cottam B, Bambina S, Bahjat KS, Crittenden M, Gough M. Intratumoral injection of STING ligand promotes abscopal effect Journal For Immunotherapy of Cancer. 2: 158. DOI: 10.1186/2051-1426-2-S3-P158 |
0.329 |
|
2013 |
Crittenden MR, Savage T, Cottam B, Bahjat KS, Redmond WL, Bambina S, Kasiewicz M, Newell P, Jackson AM, Gough MJ. The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor. Plos One. 8: e69527. PMID 23936036 DOI: 10.1371/Journal.Pone.0069527 |
0.329 |
|
2013 |
Shugart JA, Bambina S, Alice AF, Montler R, Bahjat KS. A self-help program for memory CD8+ T cells: positive feedback via CD40-CD40L signaling as a critical determinant of secondary expansion. Plos One. 8: e64878. PMID 23717671 DOI: 10.1371/Journal.Pone.0064878 |
0.37 |
|
2010 |
Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N. CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. Plos One. 5: e11144. PMID 20585396 DOI: 10.1371/Journal.Pone.0011144 |
0.436 |
|
2009 |
Bahjat KS, Meyer-Morse N, Lemmens EE, Shugart JA, Dubensky TW, Brockstedt DG, Portnoy DA. Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria. Plos Pathogens. 5: e1000568. PMID 19730694 DOI: 10.1371/Journal.Ppat.1000568 |
0.412 |
|
2009 |
Leong ML, Hampl J, Liu W, Mathur S, Bahjat KS, Luckett W, Dubensky TW, Brockstedt DG. Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice. Infection and Immunity. 77: 3958-68. PMID 19528221 DOI: 10.1128/Iai.01274-08 |
0.323 |
|
2009 |
Krebs P, Barnes MJ, Lampe K, Whitley K, Bahjat KS, Beutler B, Janssen E, Hoebe K. NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses Blood. 113: 6593-6602. PMID 19406986 DOI: 10.1182/Blood-2009-01-201467 |
0.425 |
|
2008 |
Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. The Journal of Clinical Investigation. 118: 3990-4001. PMID 19033668 DOI: 10.1172/Jci31350 |
0.459 |
|
2008 |
Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill AV, Bartholomay LC, Harty JT. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proceedings of the National Academy of Sciences of the United States of America. 105: 14017-22. PMID 18780790 DOI: 10.1073/Pnas.0805452105 |
0.352 |
|
2008 |
Lauer P, Hanson B, Lemmens EE, Liu W, Luckett WS, Leong ML, Allen HE, Skoble J, Bahjat KS, Freitag NE, Brockstedt DG, Dubensky TW. Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains. Infection and Immunity. 76: 3742-53. PMID 18541651 DOI: 10.1128/Iai.00390-08 |
0.312 |
|
2008 |
Skoberne M, Yewdall A, Bahjat KS, Lemmens E, Liu W, Lauer P, Luckett W, Dubensky TW, Brockstedt DG, Bhardwaj N. Use of KBMA Listeria monocytogenes as an antigen loading platform for dendritic cell-mediated induction of antitumor immunity Journal of Clinical Oncology. 26: 3044-3044. DOI: 10.1200/Jco.2008.26.15_Suppl.3044 |
0.469 |
|
2007 |
Bahjat KS, Prell RA, Allen HE, Liu W, Lemmens EE, Leong ML, Portnoy DA, Dubensky TW, Brockstedt DG, Giedlin MA. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 7376-84. PMID 18025181 DOI: 10.4049/Jimmunol.179.11.7376 |
0.361 |
|
2006 |
Bahjat KS, Liu W, Lemmens EE, Schoenberger SP, Portnoy DA, Dubensky TW, Brockstedt DG. Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Infection and Immunity. 74: 6387-97. PMID 16954391 DOI: 10.1128/Iai.01088-06 |
0.394 |
|
2006 |
Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity. 24: 787-99. PMID 16782034 DOI: 10.1016/J.Immuni.2006.03.024 |
0.437 |
|
2006 |
Yoshimura K, Jain A, Allen HE, Laird LS, Chia CY, Ravi S, Brockstedt DG, Giedlin MA, Bahjat KS, Leong ML, Slansky JE, Cook DN, Dubensky TW, Pardoll DM, Schulick RD. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Research. 66: 1096-104. PMID 16424046 DOI: 10.1158/0008-5472.Can-05-2307 |
0.359 |
|
2005 |
Brockstedt DG, Bahjat KS, Giedlin MA, Liu W, Leong M, Luckett W, Gao Y, Schnupf P, Kapadia D, Castro G, Lim JY, Sampson-Johannes A, Herskovits AA, Stassinopoulos A, Bouwer HG, et al. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nature Medicine. 11: 853-60. PMID 16041382 DOI: 10.1038/Nm1276 |
0.327 |
|
2005 |
Oberholzer A, Oberholzer C, Efron PA, Scumpia PO, Uchida T, Bahjat K, Ungaro R, Tannahill CL, Murday M, Bahjat FR, Tsai V, Hutchins B, Moldawer LL, Laface D, Clare-Salzler MJ. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis. Shock (Augusta, Ga.). 23: 507-15. PMID 15897802 DOI: 10.1097/01.Shk.0000163208.29655.74 |
0.731 |
|
2005 |
Oberholzer C, Tschoeke SK, Bahjat K, LaFace D, Hutchins B, Clare-Salzler MJ, Moldawer LL, Oberholzer A. In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases. Scandinavian Journal of Immunology. 61: 309-15. PMID 15853912 DOI: 10.1111/J.1365-3083.2005.01574.X |
0.643 |
|
2005 |
Brockstedt DG, Hampl J, Bahjat K, Lutz E, Leong M, Liu W, Pardoll D, Giedlin M, Jaffee E, Dubensky T. Characterization of Mesothelin-Specific T Cell Responses in Healthy Individuals Journal of Immunotherapy. 28: 631. DOI: 10.1097/01.Cji.0000191007.62728.66 |
0.324 |
|
2004 |
Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proceedings of the National Academy of Sciences of the United States of America. 101: 13832-7. PMID 15365184 DOI: 10.1073/Pnas.0406035101 |
0.376 |
|
2004 |
Brockstedt DG, Skoberne M, Yewdall A, Bahjat KS, Corash L, Dubensky TW, Bhardwaj N. Killed but Metabolically Active Recombinant Listeria monocytogenes as an Antigen Delivery and Activation Platform for Human Dendritic Cell-Based Cancer Immunotherapy. Blood. 104: 3447-3447. DOI: 10.1182/Blood.V104.11.3447.3447 |
0.472 |
|
2003 |
Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, et al. Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset. Pediatric Diabetes. 4: 10-8. PMID 14655518 DOI: 10.1034/J.1399-5448.2003.00042.X |
0.647 |
|
2002 |
Oberholzer A, Oberholzer C, Bahjat KS, Ungaro R, Tannahill CL, Murday M, Bahjat FR, Abouhamze Z, Tsai V, LaFace D, Hutchins B, Moldawer LL, Clare-Salzler MJ. Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 168: 3412-8. PMID 11907099 DOI: 10.4049/Jimmunol.168.7.3412 |
0.77 |
|
2001 |
Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y, Balk SB, Strominger JL, Clare-Salzer M, Wilson SB. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proceedings of the National Academy of Sciences of the United States of America. 98: 13838-43. PMID 11707602 DOI: 10.1073/Pnas.251531798 |
0.376 |
|
2000 |
Whittaker DS, Bahjat KS, Moldawer LL, Clare-Salzler MJ. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production. Journal of Immunology (Baltimore, Md. : 1950). 165: 4298-304. PMID 11035064 DOI: 10.4049/Jimmunol.165.8.4298 |
0.682 |
|
1999 |
Ottendorfer E, Ellis TM, Bahjat KS, Clare-Salzler M, Atkinson MA. No alteration in T lymphocyte expression of CD40 ligand (CD154) in individuals with or at increased risk for insulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism. 84: 4068-4072. PMID 10566651 DOI: 10.1210/Jcem.84.11.6107 |
0.646 |
|
Show low-probability matches. |